Pfizer Inc

Mar 12, 07
	NEW STORY
14:00 ET	Pfizer Invites Public to View and Listen to Webcasts of Pfizer Presentations at Healthcare Conferences
Mar 07, 07
10:18 ET	Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
Mar 02, 07
12:40 ET	Lipitor Significantly Reduced the Risk of Serious Cardiovascular Events Compared With Simvastatin in an 80,000-Patient Analysis of a Real-World Managed Care Database
Mar 01, 07
15:00 ET	Pfizer's Maraviroc, Novel Medicine For HIV, Significantly Reduces Viral Load, in Combination Therapy Across Range of Treatment-Experienced Patients
Feb 27, 07
15:28 ET	Pfizer Wins Challenge to Norvasc Patent by Mylan
Feb 23, 07
10:30 ET	Pfizer Board of Directors Elects Constance J. Horner to Serve as Lead Director
08:07 ET	Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor Product
04:00 ET	Celebrex Label Extended for New Use in Europe
Feb 13, 07
07:00 ET	Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe
Feb 09, 07
15:45 ET	First Meeting of the Working Group on Advisory Vote on Executive Pay Disclosure
Feb 08, 07
15:50 ET	Pfizer's Sutent Receives FDA Approval to Include New First-Line Advanced Kidney Cancer Data in Label
Feb 07, 07
14:52 ET	New Analysis Shows That Intensive Lipitor Therapy Cuts the Risk of Hospitalizations Due to Heart Failure in Patients with Coronary Heart Disease
Feb 01, 07
10:00 ET	Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline
Jan 31, 07
16:02 ET	Court Rules In Pfizer's Favor In Norvasc Patent Case, Finds Synthon Obtained Patent By Inequitable Conduct
Jan 25, 07
20:44 ET	Pfizer Gains Favorable Ruling From Canadian Court on Lipitor Basic Patent, Will Appeal Ruling on Calcium Salt Patent
Jan 22, 07
12:28 ET	Pfizer Announces Priorities to Drive Improved Performance, Position Company for Future Success and Enhance Total Shareholder Return
06:30 ET	Pfizer Achieves Key 2006 Financial Targets
Jan 19, 07
17:02 ET	Pfizer Animal Health Completes Acquisition of Embrex, Inc.
Jan 18, 07
04:00 ET	Pfizer's Sutent(R) Is Granted Full Marketing Authorization for First-Line Use in Advanced Kidney Cancer in the European Union
Jan 16, 07
14:06 ET	Pfizer Invites Public to View and Listen to Webcast of January 22 Meeting with Analysts
Dec 20, 06
17:36 ET	Pfizer Completes Sale of Consumer Healthcare Business
10:00 ET	Pfizer Launches On-Line Site for Tracking Development Compounds Across its Largest-Ever Pipeline
Dec 19, 06
19:08 ET	Australian Federal Court Upholds Basic Lipitor Patent, Preventing Launch of Generic Ranbaxy Product
Dec 18, 06
16:30 ET	Pfizer Board of Directors Names Chief Executive Officer Jeffrey B. Kindler Chairman of the Board
Dec 14, 06
13:09 ET	New Data On Pfizer's Aromasin and Ellence to Be Presented at San Antonio Breast Cancer Symposium
11:31 ET	Court Denies Novo Nordisk's Motion for Preliminary Injunction Against Exubera
Dec 08, 06
08:45 ET	Canadian Federal Court Upholds Lipitor Patent, Decision Will Prevent Launch of Generic Product Until 2010
Dec 02, 06
21:11 ET	In Interests of Patient Safety, Pfizer Stops All Torcetrapib Clinical Trials; Company Has Notified FDA and is in the Process of Notifying All Clinical Investigators and Other Regulatory Authorities
Dec 01, 06
00:01 ET	Pfizer Announces Plans to Establish Expanded Access Program for Maraviroc, Investigational HIV CCR5 Antagonist
Nov 30, 06
08:12 ET	Pfizer Presents Robust and Diversified Product Pipeline Across 11 Therapeutic Areas
Nov 28, 06
16:33 ET	As Initial Step in Transformation Strategy and Review of All Business Units, Pfizer to Align U.S. Sales Organization to Support Its Key Products and Customer Needs
02:05 ET	Organon and Pfizer Discontinue Their Collaboration on Asenapine
Nov 22, 06
14:46 ET	Pfizer Invites Public to Listen to Webcast of November 30 Meeting With Analysts
Nov 21, 06
08:45 ET	Pfizer Announces Settlement With Teva on Patents Covering Cancer Medicine and Antibiotic
Nov 15, 06
16:06 ET	Intensive Lipitor Therapy Reduced Heart Attack and Stroke By One-Third In Patients With Chronic Kidney Disease, New Analysis Shows
12:22 ET	Results of New Combined Analysis Concludes Patients at Risk for Glaucoma Will Benefit From Risk Assessment Tool
08:30 ET	Pfizer Animal Health Agrees to Acquire Embrex, Inc., the Leader in 'In Ovo' Poultry Vaccine-Delivery Technology
Oct 31, 06
09:20 ET	Pfizer Updates Preliminary Results of Torcetrapib/Atorvastatin Clinical Trials as Abstract for Phase 3 Study is Released
Oct 27, 06
12:40 ET	European Patent Office Supports Validity of Lipitor Patent
Oct 26, 06
08:00 ET	Dennis A. Ausiello To Join Pfizer Board of Directors
08:00 ET	Pfizer Declares a 24-Cent Fourth-Quarter, 2006, Dividend
05:00 ET	Pfizer Assists World Health Organization in Search for New Treatments Against Diseases of the Developing World
Oct 23, 06
14:33 ET	U.S. Appeals Court Denies Ranbaxy Petition for Rehearing Regarding Main Patent in Lipitor Case
Oct 19, 06
07:03 ET	Pfizer to Transform In Rapidly Changing Healthcare Environment
Oct 17, 06
04:58 ET	Austrian Patent Office Rules in Pfizer's Favor, Ranbaxy Product Would Infringe Basic Lipitor Patent
Oct 13, 06
10:11 ET	Pfizer Names Senior Executive to Head Expanded Worldwide Licensing and Business Development
Oct 09, 06
08:00 ET	Pfizer Expands Commitment to Fight Infectious Diseases With Agreement to Acquire Vaccine Company PowderMed Ltd
Oct 05, 06
09:00 ET	Pfizer Invites Public to Listen to Webcast of October 19 Conference Call with Analysts
Sep 29, 06
06:00 ET	Pfizer's Anti-Smoking Pill Champix(R) Approved in Europe
Sep 26, 06
05:00 ET	Pfizer Expands Research Commitment to Ophthalmology Through Licensing Agreement With Quark Biotech
Sep 22, 06
16:43 ET	Pfizer Invites Public to Listen to Webcast of September 26 Investor Conference Presentation
Sep 20, 06
17:27 ET	Pfizer Commits $15 Million Through President Clinton's Global Initiative to Address Critical Treatment Gaps in Malaria
Sep 18, 06
17:41 ET	Pfizer Invites Public to Listen to Webcast of September 20 Investor Conference Speech
14:24 ET	Pfizer's Lyrica(R) Approved in Europe for Difficult-to-Treat Nerve Pain
08:11 ET	Pfizer and TransTech Pharma Enter Into Agreement for the Development and Commercialization of Rage Modulators
Sep 14, 06
03:10 ET	Exubera Effective in Diabetes Patients who Have Respiratory Infections or are Exposed to Passive Cigarette Smoke, New Analyses Show
03:07 ET	Exubera Effective in Diabetes Patients who Have Respiratory Infections or are Exposed to Passive Cigarette Smoke, New Analyses Show
Sep 13, 06
04:39 ET	Court in the Netherlands Upholds Basic Lipitor Patent, Prevents Launch of Ranbaxy Product Before November 2011
Sep 08, 06
15:26 ET	Pfizer Invites Public to Listen to Webcast of September 12 Investor Conference Presentation
Sep 06, 06
03:30 ET	Lipitor More Effective Than Simvastatin in Cutting Risk of Additional Heart Attacks in Patients Who Had a Recent Heart Attack, New Data Suggests
Sep 01, 06
08:38 ET	Pfizer Wins Norvasc Patent Challenge by Generic Manufacturer Synthon
Aug 30, 06
09:19 ET	Norway Court Decision 'Has No Practical Effect on Pfizer's Ability to Protect Lipitor from the Launch of a Competitor Generic Product By Ranbaxy'
Aug 17, 06
16:18 ET	Jury Rules Unanimously in Pfizer's Favor in Amlodipine Patent Case
Aug 15, 06
16:36 ET	Pfizer CEO Jeff Kindler Announces New Leadership Organization That Will 'Put Us in the Best Possible Position to Capitalize Quickly on the Enormous Opportunities Ahead'
Aug 09, 06
17:05 ET	Pfizer's Lipitor Shown to Reduce the Chance of Additional Strokes in Stroke Patients
Aug 02, 06
14:09 ET	U.S. Appeals Court Upholds Lipitor's Basic Patent With Exclusivity Maintained in U.S. Until March, 2010
Aug 01, 06
11:33 ET	Pfizer's CHANTIX(TM) (Varenicline) Now Available To Help Smokers Quit
Jul 28, 06
17:56 ET	Pfizer Board of Directors Names Jeffrey B. Kindler Chief Executive Officer
Jul 20, 06
06:43 ET	Pfizer Delivers Strong Second-Quarter 2006 Results, Driven By Performance Of Major In-Line And New Products
Jul 17, 06
09:46 ET	Pfizer to Hold Conference Call With Analysts to Review Reclassified Quarterly 2005 and 2006 Consolidated Statements of Income Reflecting Consumer Healthcare Business As Discontinued Operation
Jul 11, 06
08:00 ET	Pfizer Invites Public to Listen to Webcast of July 20 Conference Call With Analysts
Jul 04, 06
16:00 ET	Data Show CHANTIX(TM) (varenicline) Provides Smokers New Hope to Quit Smoking
Jun 28, 06
06:23 ET	British Appellate Court Rules In Pfizer's Favor In Challenge To Basic Lipitor Patent
Jun 26, 06
06:00 ET	Pfizer Reaches Agreement to Sell Its Consumer Healthcare Business to Johnson & Johnson for $16.6 Billion
Jun 22, 06
17:14 ET	Pfizer to Return Indiplon Worldwide Rights to Neurocrine
13:06 ET	Pfizer Declares a 24-Cent Third-Quarter, 2006, Dividend
Jun 14, 06
08:00 ET	Pfizer Enters Into Agreement with Bayer to License Compounds for Potential Treatment of Obesity, Diabetes and Related Disorders
Jun 13, 06
06:50 ET	Pfizer Completes Acquisition of Worldwide Rights to New Drug Candidate Fesoterodine From Schwarz Pharma AG
Jun 09, 06
15:38 ET	New Exubera Data to Be Presented at American Diabetes Association Meeting
11:23 ET	Pfizer Statement on Lipitor
Jun 01, 06
15:15 ET	More Than 100 Studies From Pfizer's Extensive Oncology Portfolio to Be Presented at ASCO 2006
May 15, 06
13:34 ET	Pfizer's Lipitor Provides Greater Reductions in Heart Attack, Stroke and Cardiovascular Procedures at an Overall Cost Savings Compared to Zocor, New Analysis Shows
May 11, 06
10:01 ET	Pfizer's Smoking Cessation Medicine Chantix(TM) (Varenicline) Receives FDA Approval
May 08, 06
08:00 ET	Pfizer and Monogram to Make HIV Co-Receptor Tropism Assay Available Globally
May 02, 06
16:46 ET	Pfizer Announces Support of Cover the Uninsured Week
May 01, 06
16:29 ET	Pfizer Invites Public to Access Webcasts of Pfizer's Participation at Investor Conferences
Apr 28, 06
07:56 ET	Pfizer's Sutent Receives Positive Opinion in the European Union For Two Difficult-To-Treat Advanced Cancers
Apr 27, 06
13:26 ET	Pfizer Statement on 2006 Shareholder Meeting
09:03 ET	Pfizer Declares a 24-Cent Second-Quarter, 2006, Dividend
Apr 25, 06
14:30 ET	Pfizer Says Austrian Court Ruling on Lipitor Enantiomer Patent Has No Effect on Cases in Other Jurisdictions
12:53 ET	Pfizer Invites Public to Access Webcast of April 27 Annual Meeting of Shareholders
Apr 19, 06
06:38 ET	Pfizer First-Quarter 2006 Financial Results Reflect Operating and Financial Strength
Apr 13, 06
01:23 ET	Pfizer Expands Commitment to Urology With Agreement to Acquire Worldwide Rights to New Drug Candidate Fesoterodine
Apr 12, 06
15:17 ET	Pfizer Invites Public to Listen to Webcast of April 19 Conference Call With Analysts
Apr 06, 06
19:09 ET	Pfizer to Expand Neuroscience Research With Acquisition of Biotech Company Rinat Neuroscience
Apr 04, 06
08:29 ET	New Global Survey Shows Most People Are Concerned About Antibiotic Resistance But Many Don't Link Problem With Improper Use of Medicines
Apr 03, 06
09:02 ET	New Research Shows That Celebrex Helps Stop Growth of Pre-Cancerous Colorectal Polyps in Patients at High Risk for Colon Cancer
Mar 27, 06
09:08 ET	Pfizer's Lyrica Approved for the Treatment of Generalized Anxiety Disorder (GAD) in Europe
Mar 14, 06
09:03 ET	New Torcetrapib/Atorvastatin Research Further Supports Raising 'Good' HDL Cholesterol
Mar 13, 06
13:00 ET	'Only Lipitor Has Demonstrated Significant LDL Reductions and Cardiovascular Benefits for a Wide Range of Patients, With an Excellent Efficacy and Safety Profile Across the Full Dose Range'
11:45 ET	Lipitor Demonstrates Improvement in Kidney Function in Patients With Coronary Heart Disease, New Analysis Shows
Mar 10, 06
14:40 ET	Pfizer Making Significant Contribution to Pharmaceutical Industry Health Partnerships in Developing Countries
Mar 01, 06
10:23 ET	Pfizer Completes Acquisition of Worldwide Rights to Exubera From sanofi-aventis
Feb 23, 06
09:01 ET	PFIZER Announces New Class of Global Health Fellows
Feb 21, 06
15:50 ET	Finland Court Enjoins Ranbaxy From Marketing Generic Lipitor
10:44 ET	Pfizer Receives FDA Approval for Eraxis(TM) to Treat Candidemia, a Potentially Life-Threatening Bloodstream Infection
Feb 10, 06
09:03 ET	Pfizer Driving Performance Through Growth of Current and New Medicines, Productivity Improvements and Strategies to Capitalize on New Market Opportunities
Feb 08, 06
17:06 ET	Pfizer Petitions FDA to Recall Teva and Sandoz Generic Azithromycin Products to Correct Misbranding
11:20 ET	Genetic Association Information Network Launched
Feb 07, 06
17:35 ET	Pfizer to Explore Strategic Alternatives for Consumer Healthcare Business
Feb 03, 06
10:00 ET	Pfizer Invites Public to Listen to Webcast of February 10 Meeting With Analysts
Feb 02, 06
12:14 ET	European Commission Approves Macugen for Treatment of All Types of Wet Age-Related Macular Degeneration; First Treatment to Target Underlying Disease Process of Wet AMD
Jan 27, 06
16:35 ET	Pfizer Receives FDA Approval for Exubera, the First Inhalable Form of Insulin for Controlling Type 1 and Type 2 Diabetes in Adults
11:24 ET	Pfizer's Lyrica Receives Positive Opinion From CHMP for the Treatment of Generalized Anxiety Disorder in Adults
07:38 ET	Pfizer Statement on Status of Exubera Filing in the U.S.
Jan 26, 06
12:04 ET	European Commission Approves Exubera(R) (Inhaled Human Insulin) for Treatment of Type 1 and Type 2 Diabetes
Jan 24, 06
10:06 ET	Pfizer Names Amal Naj Vice President, Investor Development and Strategy
Jan 19, 06
06:40 ET	Pfizer Fourth-Quarter and Full-Year 2005 Financial Results Reflect Operating and Financial Strength
Jan 18, 06
13:00 ET	Pfizer Wins Norvasc Patent Challenge by Generic Manufacturer Apotex
Jan 17, 06
11:58 ET	Lipitor's Safety Again Confirmed in Extensive Analysis of 49 Clinical Trials, Pfizer Says
Jan 13, 06
09:00 ET	Pfizer Invites Public to Listen to Webcast of January 19 Conference Call With Analysts
Jan 12, 06
19:58 ET	Pfizer to Acquire the Sanofi-Aventis Worldwide Rights to Exubera(R) (Inhaled Human Insulin)
Jan 06, 06
11:04 ET	Pfizer Introduces Radio Frequency Identification Technology to Combat Counterfeiting, Protect Patient Health
Dec 30, 05
11:00 ET	Pfizer Invites Public to Listen to Webcast of January 4 Conference Participation By Dr. Hank McKinnell
Dec 21, 05
13:45 ET	Pfizer's Varenicline Receives U.S. FDA Priority Review
Dec 20, 05
17:01 ET	Spanish Court Rules in Pfizer's Favor on Lipitor Patent Challenge
Dec 16, 05
19:09 ET	Updated: Pfizer Prevails in Challenges to Lipitor Patents in the United States
17:27 ET	Pfizer Prevails in Challenges to Lipitor Patents in the United States
Dec 12, 05
15:07 ET	Pfizer Increases Dividend 26 Percent to 24 Cents Per Share for the First Quarter of 2006 as Part of Ongoing Actions to Leverage Financial Strengths and Enhance Shareholder Value
Nov 29, 05
12:22 ET	U.S. Patent Office To Issue Decision Confirming Validity of Pfizer's Crystalline Patent For Lipitor
Nov 22, 05
16:56 ET	Appeals Court Upholds Preliminary Injunction Against Ranbaxy and Teva, in Generic Quinapril Patent Case
Nov 21, 05
06:00 ET	Pfizer and Incyte Enter Collaborative Research and License Agreement for the Development and Commercialization of CCR2 Antagonists
Nov 16, 05
17:15 ET	Published Study Shows Benefits of Revatio (Sildenafil Citrate) in Patients With Pulmonary Arterial Hypertension
Nov 15, 05
10:01 ET	Pfizer's Torcetrapib/Atorvastatin Significantly Raised 'Good' Cholesterol While Lowering 'Bad' Cholesterol, New Data Show
09:08 ET	New Data: Pfizer's Varenicline is an Effective and Safe Treatment for Smoking Cessation
09:01 ET	New Lipitor Study Demonstrates That Intensive LDL Cholesterol Lowering in Heart Disease Patients Can Reduce Cardiovascular Events, Pfizer Says
Nov 13, 05
09:39 ET	New Data Show Hypertensive Patients Taking Norvasc-Based Regimen Achieved Better Central Blood Pressure Control
Nov 09, 05
13:37 ET	Pfizer Prevails in Norwegian Lipitor Patent Challenge
Nov 04, 05
09:04 ET	Pfizer's Revatio Receives European Approval to Treat Pulmonary Arterial Hypertension
Oct 31, 05
14:40 ET	Pfizer's Zeldox Receives Approval in Europe to Treat Manic or Mixed Episodes Associated With Bipolar Disorder
Oct 28, 05
11:50 ET	Pfizer and sanofi-aventis Statement on Status of Exubera
Oct 27, 05
16:35 ET	Pfizer Amends Corporate Governance Principles to Clarify New Majority Voting Policy
14:18 ET	Pfizer Declares a 19-Cent Fourth-Quarter, 2005, Dividend
Oct 20, 05
06:47 ET	Pfizer Inc Third-Quarter 2005 Performance Report
Oct 14, 05
09:00 ET	New HIV/AIDS Care Center - Big Boost for The AIDS Support Organization (TASO) and Uganda Infrastructure
Oct 13, 05
14:40 ET	Exubera(R) Receives Positive Opinion from CHMP for the Treatment of Type 1 and Type 2 Diabetes
11:28 ET	Pfizer Invites Public to Listen to Webcast of October 20 Conference Call With Analysts
10:00 ET	Earthquake Assistance: Pfizer to Provide $1 Million to Relief Organization and up to $5 Million Worth of Medicines
Oct 12, 05
09:09 ET	Pfizer Prevails in Challenge to Basic Lipitor Patent in British High Court
Oct 06, 05
15:17 ET	Major Public Health Initiative Created to Lead Battle Against Growing MRSA Burden
Oct 05, 05
14:10 ET	FDA Approves Pfizer's Aromasin(R) for Adjuvant Treatment of Early Breast Cancer in Postmenopausal Women
Oct 03, 05
10:41 ET	Pfizer Provides Easier, Broader Access to Clinical Trial Information
Sep 28, 05
08:02 ET	Pfizer Board of Directors Elects Stanley O. Ikenberry to Serve as Lead Director
Sep 27, 05
08:30 ET	FDA Approves Pfizer's Lipitor(R) to Reduce Risk of Strokes and Heart Attacks in Patients With Diabetes
Sep 21, 05
16:00 ET	Pfizer Expands Hurricane Katrina Relief Effort
08:31 ET	Pfizer's Lyrica Now Available for Patients
Sep 20, 05
08:30 ET	Pfizer Receives FDA Non-Approvable Letter on Parecoxib
Sep 16, 05
08:30 ET	Macugen Receives Positive Opinion From Europe's CHMP for Treatment of Wet Age-Related Macular Degeneration
Sep 14, 05
03:00 ET	Pfizer Completes Acquisition of Vicuron Pharmaceuticals
Sep 13, 05
09:13 ET	Pfizer Statement on Lasofoxifene
08:35 ET	Pfizer Receives European Approval to Market Aromasin(R) for Adjuvant Treatment of Early Breast Cancer in Postmenopausal Women
Sep 11, 05
12:00 ET	Pfizer Expects Acquisition of Vicuron Pharmaceuticals to Close on September 14, 2005
Sep 08, 05
18:10 ET	FDA Advisory Committee Recommends Approval of Exubera(R) for Use in Adults With Type 1 and 2 Diabetes
Sep 04, 05
12:30 ET	Patients Taking A Regimen Based On Pfizer's Norvasc Experienced Significant Reductions In Cardiovascular Death, Landmark Study Shows
Sep 02, 05
17:02 ET	Pfizer Partners With Pharmacies To Expand Relief Aid To Hurricane Katrina Victims
Aug 31, 05
16:20 ET	Pfizer Commits $2 Million and Healthcare Products for Relief and Recovery Efforts to Help the Victims of Hurricane Katrina
Aug 15, 05
15:22 ET	Pfizer Acquires Antibody Discovery and Optimization Company
Aug 11, 05
08:00 ET	Pfizer Announces Improvements to Consumer Advertising for Prescription Medicines
Aug 10, 05
08:35 ET	Pfizer Submits Application for Sutent to FDA
Aug 02, 05
16:54 ET	Pfizer Statement On PhRMA Principles
13:00 ET	Leslie Mays Joins Pfizer in New Diversity Leadership Position
13:00 ET	Loretta M. Ucelli to Join Pfizer as Senior Vice President, Corporate Communications
Aug 01, 05
10:40 ET	FDA Approves New Use for Pfizer's Celebrex; Finalizes Prescribing Information, Including Expected Warnings, for All Six Approved Uses --- Patients with Ankylosing Spondylitis, a Debilitating Form of Arthritis, Now Have New Treatment Option with Celebrex -
Jul 26, 05
10:01 ET	Phase 1/2a Study Results Indicate Maraviroc Well-Tolerated In Doses Up To 300 mg Twice-Daily
Jul 21, 05
08:50 ET	Pfizer Statement on SUTENT Regulatory Submission
Jul 20, 05
06:30 ET	Pfizer Inc Second-Quarter 2005 Performance Report
Jul 14, 05
09:02 ET	Pfizer Invites Public to Listen to Webcast of July 20 Conference Call With Analysts
Jul 01, 05
08:00 ET	Pfizer Provides Update on Two R&D Pipeline Developments
Jun 27, 05
18:18 ET	Pfizer Said Review of All Ocular Event Reports Concludes No Evidence of Increased Risk of Blindness Among Viagra Patients
Jun 24, 05
15:46 ET	Pfizer Statement: Key Facts Regarding U.S. Supreme Court Hearing
09:03 ET	Jean-Paul Valles Leaves Pfizer Board of Directors
Jun 23, 05
14:00 ET	Pfizer to Repatriate Additional $8.6 Billion in Foreign Earnings
13:00 ET	Pfizer to Amend Corporate Governance Principles Regarding Election of Directors
13:00 ET	Pfizer to Purchase Up to $5 Billion of Common Stock
Jun 22, 05
14:06 ET	Pfizer Statement on Patent Office Communication
08:39 ET	Pfizer Begins Production at Torcetrapib/Atorvastatin Manufacturing Facility; Major Milestone for Potential Cardiovascular Medicine
Jun 16, 05
01:00 ET	Pfizer to Acquire Vicuron Pharmaceuticals to Extend Its Research Commitment in Anti-Infectives
Jun 15, 05
15:27 ET	Pfizer Very Pleased by Moody's Reaffirmation of Aaa Rating
Jun 14, 05
13:00 ET	Data Presented at American Diabetes Association Scientific Sessions Support Exubera(R) Efficacy and Safety Profile In Type 1 and Type 2 Diabetes
Jun 13, 05
14:59 ET	Pfizer's Single-Dose Antibiotic Zmax(TM) Receives FDA Approval
08:39 ET	FDA Approves Pfizer's Lyrica as Epilepsy Add-On Treatment for Partial Onset Seizures
08:35 ET	New Data Analysis Shows Patients With Diabetes Taking Pfizer's Lipitor(R) Experienced Major Reductions in Heart Attack and Stroke
Jun 06, 05
08:54 ET	FDA Approves Pfizer's Revatio As Treatment for Pulmonary Arterial Hypertension
May 24, 05
18:27 ET	Pfizer Statement on Appropriate Use of ED Treatments
May 14, 05
17:00 ET	New Data Show Pfizer's SUTENT/SU11248 (sunitinib malate) Extends Overall Survival in Gleevec-resistant GIST
May 10, 05
14:32 ET	Pfizer Statement on Status of Bextra
Apr 28, 05
13:00 ET	Pfizer Declares a 19-Cent Second-Quarter, 2005, Dividend
Apr 22, 05
15:28 ET	Pfizer Follows Up on February 2005 Recall of One Lot of Epilepsy Medicine
Apr 21, 05
15:13 ET	Pfizer Invites Public to View Webcast of April 28 Annual Meeting of Shareholders
Apr 20, 05
13:20 ET	Pfizer Says Sale of Illegal and Unapproved Drugs Is Growing Threat to U.S. Patients; Applauds Announcement by Department of Justice
Apr 19, 05
07:01 ET	/SECOND AND FINAL ADD -- NYTU041B -- Pfizer Inc Earnings/
07:00 ET	/FIRST ADD -- NYTU041B -- Pfizer Inc Earnings/
06:59 ET	Pfizer Inc First-Quarter 2005 Performance Report
Apr 14, 05
08:01 ET	Pfizer Opens Clinical Research Unit In New Haven
Apr 13, 05
12:05 ET	Pfizer Invites Public to Listen to Webcast of April 19 Conference Call With Analysts
Apr 07, 05
09:21 ET	New FDA Labeling for Pfizer's Celebrex and All Other NSAIDs to Reflect Similar Cardiovascular Profile
Apr 05, 05
14:05 ET	Pfizer Joins National Outreach Effort To Help Patients Access Medicines
09:05 ET	Pfizer Sees Sustained Long-Term Growth Driven By Innovative Products, Strong R&D Pipeline and Operating Efficiencies
Mar 29, 05
17:26 ET	Pfizer Awarded Preliminary Injunction Blocking Teva/Ranbaxy From Selling Generic Quinapril
17:06 ET	Pfizer Invites Public to Listen to Webcast of April 5 Meeting With Analysts
11:20 ET	Pfizer to Appeal Austrian Lipitor Patent Decision
08:02 ET	FDA Approves Pfizer's Depo-subQ provera 104(TM) for Management of Endometriosis Pain
Mar 24, 05
12:38 ET	Pfizer, Coley Pharmaceutical Group Enter Into Exclusive Global License For The Development and Commercialization of ProMune(TM) for Cancers
Mar 08, 05
09:21 ET	Initial Results of Large Hypertension Study Reaffirms Norvasc's Therapeutic Benefits to Patients, Pfizer Says
09:21 ET	Lipitor Patients Who Reduced 'Bad' Cholesterol To Very Low Levels Show Significant Decrease in Heart Attack and Stroke, New Data Show
Mar 07, 05
16:46 ET	Pfizer Names Anthony Principi VP, Government Relations
Mar 03, 05
08:40 ET	Pfizer and New York University School of Medicine Announce the Launch of an Online Men's Sexual Health Referral Network
Mar 02, 05
08:03 ET	Pfizer and the Sanofi-Aventis Group Seek Approval to Market Exubera(R) in the United States
Feb 24, 05
14:31 ET	Pfizer Names Three Senior Executives Vice Chairman, Appoints New Chief Financial Officer and Head of Human Resources
08:01 ET	Pfizer to Acquire Idun Pharmaceuticals
Feb 17, 05
14:32 ET	Pfizer Statement: Key Facts Regarding U.S. Supreme Court Hearing
Feb 14, 05
10:48 ET	Pfizer's LYRICA(TM) Results in 50 Percent Fewer Partial Seizures, New Study Shows
Feb 10, 05
07:46 ET	Pfizer and Microsoft Target Sellers of Illegal Viagra and International Spam Rings
Feb 08, 05
09:03 ET	Pfizer Cancer Drug Demonstrates Early Efficacy and Safety; Placebo Patients to Switch Immediately to Drug Therapy
Feb 04, 05
12:45 ET	Physician Groups Address Disparities in Healthcare
Feb 03, 05
12:24 ET	Pfizer to Reschedule Hank McKinnell National Press Club Speech
Feb 02, 05
09:08 ET	Pfizer Expands Tsunami Relief Efforts Across Asia
02:00 ET	Pfizer Signs Agreement With Schering AG to License Compounds for Potential Prevention of Thrombosis
Feb 01, 05
15:36 ET	Pfizer Acted Responsibly in Sharing Celebrex Alzheimer's Study Data With FDA
Jan 21, 05
15:46 ET	Appeals Court Rules in Pfizer's Favor in Patent Challenge to Zoloft
10:11 ET	First Head-To-Head Study Shows Pfizer's Geodon is Equally Effective as, and Better Tolerated Than, Risperdal For the Treatment of Schizophrenia
Jan 19, 05
06:55 ET	/SECOND AND FINAL ADD -- NYW043A -- Pfizer Inc Fourth-Quarter 2004 Performance Report/
06:53 ET	/FIRST ADD -- NYW043A -- Pfizer Inc Fourth-Quarter 2004 Performance Report/
06:51 ET	Pfizer Inc Fourth-Quarter 2004 Performance Report
Jan 13, 05
12:04 ET	Pfizer Invites Public to Listen to Webcast of January 19 Conference Call With Analysts
Dec 31, 04
08:00 ET	FDA Approves Pfizer's Lyrica(TM) for the Treatment of the Two Most Common Forms of Neuropathic (Nerve) Pain
Dec 29, 04
12:34 ET	Pfizer to Provide Medicines, Financial and Logistical Support to Relief Effort in Asia
Dec 28, 04
10:42 ET	Pfizer's Antifungal Medicine VFEND(R) Receives FDA Approval for Treatment of Serious Bloodstream Infections Caused by Candida in Nonneutropenic Patients
Dec 21, 04
09:36 ET	Pfizer Says New NIH Study Results Are Consistent With Large Body of Evidence Supporting Cardiovascular Safety of Celebrex
Dec 17, 04
09:19 ET	Pfizer Statement On New Information Regarding Cardiovascular Safety of Celebrex
Dec 13, 04
13:02 ET	Pfizer Declares a 19-Cent First-Quarter, 2005, Dividend
Dec 08, 04
13:10 ET	Hypertensive Patients Taking Pfizer's Norvasc Experienced Cardiovascular Benefits
Dec 03, 04
13:33 ET	Pfizer Submits Regulatory Filings for Revatio as a Treatment for Pulmonary Arterial Hypertension
Nov 30, 04
13:28 ET	Pfizer Sees Strong Prospects from the Industry's Premier R&D Pipeline and Expanding New Product Opportunities
Nov 17, 04
16:10 ET	Pfizer Invites Public to Listen to Webcast of November 30 Meeting With Analysts
12:15 ET	Pfizer Announces Study Results Showing That Zyrtec(R) Provides Greater Symptom Relief Than Allegra(R) for Allergy Sufferers Exposed to Ragweed Pollen in an Environmental Exposure Unit
Nov 15, 04
10:08 ET	Pfizer Plans to Incorporate RFID Technology Into Viagra Packaging in U.S.
09:01 ET	Pfizer to Expand Reno Logistics Center
Nov 12, 04
12:01 ET	Pfizer Completes Acquisition of Drug Delivery Technology Venture From PA Consulting Group
Nov 10, 04
13:55 ET	Pfizer Statement on Bextra(R) (Valdecoxib)
Nov 09, 04
16:01 ET	Pfizer's Norvasc Demonstrates Significant Reductions in Major Cardiovascular Events in Patients With Coronary Artery Disease
09:04 ET	Florida and Pfizer Report Innovative Partnership Has Delivered on Promise of Better Health at Lower Cost for Thousands of Medicaid Recipients
Nov 04, 04
17:18 ET	New Study Reaffirms Progress Towards Eliminating Blinding Trachoma
13:32 ET	Pfizer Affirms Celebrex Safety
10:28 ET	DETROL LA Combined With Standard Treatment for Enlarged Prostate is Twice as Effective in Relieving Overactive Bladder as Standard Treatment Alone
Nov 03, 04
15:00 ET	Pfizer Statement on U.S. Presidential Election
Nov 02, 04
09:01 ET	Pfizer Invests $372M to Purchase La Jolla R&D Campus; Advances Search for New Medicines in Cancer, HIV, Hepatitis, Blindness and Diabetes/Obesity
Nov 01, 04
10:30 ET	Three New Pfizer Studies Show a Single Dose of Azithromycin Microspheres Is as Effective as Multi-Dose Treatment for Respiratory Tract Infections in Adults
Oct 28, 04
14:45 ET	Nat Ricciardi Named to Lead Pfizer Global Manufacturing
12:34 ET	Pfizer to Purchase up to $5 Billion of Common Stock
Oct 20, 04
06:48 ET	/SECOND AND FINAL ADD -- NYW086 -- Pfizer Inc Earnings/
06:46 ET	/FIRST ADD -- NYW086 -- Pfizer Inc Earnings/
06:45 ET	Pfizer Inc Third-Quarter 2004 Performance Report
03:00 ET	New Infectious Diseases Institute (IDI) to Enhance Treatment of Patients and Training of Health Professionals in Sub-Saharan Africa
03:00 ET	The Power of Partnership; 'A Three-Fold Increase in the Capacity to Care for People Living With HIV/AIDS and Other Infectious Diseases, at the Makerere University in Uganda, Will Bring Benefits Across All of Africa' - Pfizer Chairman and CEO, Hank McKinne
Oct 18, 04
07:45 ET	Pfizer to Sponsor Major New Celebrex Clinical Trial
Oct 15, 04
08:01 ET	Pfizer Provides Information to Healthcare Professionals About Its COX-2 Medicine Bextra(R) (valdecoxib)
Oct 14, 04
14:36 ET	Pfizer Invites Public to Listen to Webcast of October 20 Conference Call With Analysts
Oct 13, 04
18:17 ET	Pfizer Provides Update on Neurontin Legal Developments
Oct 08, 04
17:32 ET	Pfizer Subsidiary Greenstone Launches Generic Gabapentin Product
08:24 ET	No Decision in Neurontin Patent Case
Oct 07, 04
08:08 ET	Starting Today, 45 Million Uninsured Can Fill Prescriptions for Pfizer Medicines at Significant Savings
Oct 06, 04
14:54 ET	Working Mother Names Pfizer One of '100 Best Companies For Working Mothers'
Oct 05, 04
12:30 ET	Pfizer to Acquire PURELL(R) From GOJO; Alliance With GOJO and QualPak Will Drive Expansion of Brand
Oct 01, 04
14:26 ET	No Evidence of Cardiovascular Safety Signal for Pfizer's Celebrex in Long-Term Clinical Trials of More Than 6,000 Patients
Sep 30, 04
12:11 ET	Pfizer Affirms Celebrex Safety
Sep 22, 04
16:20 ET	Pfizer to Purchase Drug Delivery Technology Venture From PA Consulting Group
Sep 20, 04
10:00 ET	Pfizer and Eyetech Provide Regulatory Update on Macugen(TM) (pegaptanib sodium injection)
Sep 07, 04
10:25 ET	New Data On EXUBERA(R) Showed Sustained Blood Glucose Control and Pulmonary Function In Patients With Type 2 Diabetes
Sep 03, 04
07:30 ET	Pfizer and Quigley Subsidiary to Resolve Legacy Asbestos Claims Through Responsible, Orderly Process
Sep 02, 04
16:11 ET	Pfizer Files Suit Against Operators of Eighteen Internet Sites Selling Illegal Copies of LIPITOR(R)
13:40 ET	Pfizer Statement on Regulatory Status of Lyrica
Sep 01, 04
16:56 ET	Pfizer Reaffirms Superior Value of U Share Card and Other Medicare-Approved Drug Discount Cards for Medicare Beneficiaries Seeking Access to Affordable Medicines
Aug 23, 04
13:03 ET	FDA Approves Pfizer's atypical antipsychotic Geodon(R) for the Treatment of Acute Bipolar Mania
Aug 20, 04
09:05 ET	Pfizer's DETROL(R) LA Effectively Treats Overactive Bladder Symptoms of Mixed Incontinence, The Most Common Type of Urinary Incontinence
Aug 18, 04
07:04 ET	Enrollment Opens for Program Providing Savings on Pfizer Medicines for 43 Million Uninsured
Aug 16, 04
15:14 ET	New ACC/AHA Stemi Guidelines Urge Early and Long-Term Treatment With Aldosterone Blockade Therapy
Aug 04, 04
10:34 ET	FDA Approves Pfizer's Lipitor(R) to Lower Risk of Heart Attacks
Aug 03, 04
08:30 ET	Pfizer Launches Campaign Against Sellers of Illegal Generic and Counterfeit Viagra and Senders of Viagra-Related Spam
Jul 28, 04
07:00 ET	Pfizer Statement on Status of Florida Medicaid Healthcare Management Program
Jul 21, 04
18:34 ET	Pfizer to Discontinue Sumanirole Development Program
06:52 ET	/SECOND AND FINAL ADD -- NYW090 -- Pfizer Inc Earnings/
06:51 ET	/FIRST ADD -- NYW090 -- Pfizer Inc Earnings/
06:49 ET	Pfizer Inc Second-Quarter 2004 Performance Report
Jul 16, 04
12:32 ET	Pfizer Helps Agency Direct N.M. Seniors to Free Medicines
Jul 15, 04
13:41 ET	Pfizer Statement on 2004 Financial Performance
Jul 14, 04
14:37 ET	Pfizer Invites Public to Listen to Webcast of July 21 Conference Call With Analysts
Jul 07, 04
17:52 ET	Pfizer Prevails in Xalatan Patent Suit
15:53 ET	Pfizer to Launch Comprehensive Initiative Expanding Access to Prescription Medicines for Millions of Americans ---- Indiana's uninsured to have access to Pfizer medicines free or at significant savings ---- Indiana families making less than $45,000 to sav
15:53 ET	Pfizer to Launch Comprehensive Initiative Expanding Access to Prescription Medicines for Millions of Americans ---- Nebraska's uninsured to have access to Pfizer medicines free or at significant savings ---- Nebraska families making less than $45,000 to s
07:12 ET	Pfizer to Launch Comprehensive Initiative Expanding Access to Prescription Medicines for Millions of Americans
Jul 06, 04
18:11 ET	Pfizer to Hold Press Conference
12:28 ET	Pfizer Receives Approval to Market Lyrica(R) for Neuropathic Pain and Add-On Epilepsy in Europe
Jul 02, 04
14:15 ET	Pfizer Reaches Agreement To Settle Rezulin Lawsuit In Illinois
Jun 30, 04
10:23 ET	Pfizer Prevails in Accupril Patent Suit
Jun 24, 04
18:34 ET	Pfizer CEO Hank McKinnell to Address United Nations Global Compact Leaders Summit on Countering Corruption
15:29 ET	Pfizer Declares a 17-Cent Third-Quarter, 2004, Dividend
08:00 ET	Nationwide Survey Reveals Migraineurs Not the Only Ones Suffering During Migraine Attacks
Jun 23, 04
10:01 ET	Pfizer's Caduet Debuts Nation Wide to Treat High Blood Pressure and High Cholesterol
Jun 14, 04
12:23 ET	New Data Shows Patients Taking Pfizer's Norvasc Achieved Superior Blood Pressure Control With Fewer Heart Attacks
Jun 11, 04
11:44 ET	Optimal Time to Treat Migraine Pain With Relpax(R) is Early in the Attack, New Study Finds
Jun 07, 04
11:00 ET	Patients With Diabetes Taking Lipitor Experienced Major Reductions in Heart Attacks and Strokes, New Data Show
10:28 ET	New Long-Term Safety and Efficacy Data On EXUBERA(R) (Human Insulin Powder) Presented at American Diabetes Association Scientific Sessions
May 27, 04
17:23 ET	California Verdict Finds Warner-Lambert Not Liable in Rezulin Trial
May 26, 04
02:40 ET	Omega Pharma Acquires a Portfolio of OTC and Personal Care Brands from Pfizer
May 18, 04
14:54 ET	Pfizer Signs Agreement With Shanghai Government to Enhance Protection of Patients
May 13, 04
11:01 ET	Pfizer Statement on Resolution of Warner-Lambert Neurontin Legal Matters
May 10, 04
14:37 ET	Efficacy Cited as #1 Reason Why Patients 'Switch Back' to Viagra(R)
May 05, 04
16:29 ET	Year-Long Studies Show Switching From Other Antipsychotic Medications to Geodon Significantly Reversed Increases in Weight Gain, Cholesterol and Triglycerides
15:57 ET	Two Studies in Patients With Acute Bipolar Mania Show Rapid and Significant Improvement in Patients Treated With Geodon(R)
May 04, 04
16:01 ET	Pfizer Files Suit Against Five Internet Sites for Selling Illegal Copy of Lipitor
08:35 ET	Pfizer to Sell Fajardo Manufacturing Facility to Galen Holdings PLC
May 03, 04
00:01 ET	European Regulators Reaffirm Pfizer's COX-2 Portfolio
Apr 28, 04
09:44 ET	U.S. Court of Appeals Affirms Pfizer's Six-Month Exclusivity for Diflucan
Apr 23, 04
16:15 ET	Pfizer Completes Sale of Its In-Vitro Allergy and Autoimmune Diagnostic Testing Business to Triton and PPM
Apr 22, 04
13:30 ET	Pfizer Declares a 17-Cent Second-Quarter, 2004, Dividend
12:50 ET	Momentum of 'Best Year Ever' in 2003 Carries Into 2004, Pfizer Chairman and CEO Hank McKinnell Tells Shareholders at Annual Meeting in St. Louis
Apr 21, 04
18:47 ET	Pfizer's Share Card Program Joins UnitedHealth Group* in Discount Card Coalition to Help Medicare Beneficiaries Save on Needed Medicines
Apr 20, 04
06:42 ET	/SECOND AND FINAL ADD -- NYTU091 -- Pfizer Inc Earnings/
06:40 ET	/FIRST ADD -- NYTU091 -- Pfizer Inc Earnings/
06:38 ET	Pfizer Inc First-Quarter 2004 Performance Report
Apr 16, 04
10:31 ET	Pfizer Invites Public to View Webcast of April 22 Annual Meeting of Shareholders
Apr 14, 04
10:14 ET	Pfizer Celebrates Sixth Anniversary of Viagra(R) By Unveiling New Patient Savings Program
08:30 ET	Pfizer Invites Public to Listen to Webcast of April 20 Conference Call With Analysts
Apr 12, 04
17:13 ET	Pfizer Files Suit Against Internet Site for Selling Copy of Lipitor
Apr 01, 04
15:08 ET	Pfizer Says Inclusion in Dow Jones Industrial Average Recognizes Company's Leadership in Increasingly Important Healthcare Sector
Mar 25, 04
15:31 ET	Pfizer's LYRICA Receives Positive Opinion in Europe From Committee for Proprietary Medicinal Products
Mar 18, 04
10:54 ET	FDA Approves New Chewable Formulation of Zyrtec(R)
Mar 11, 04
17:23 ET	Court's Ruling Supports Market Exclusivity for Pfizer's Diflucan
Mar 10, 04
10:01 ET	Breast Cancer Patients Switched to Pfizer's AROMASIN Were More Likely to Remain Cancer Free, New Study Shows
Mar 08, 04
11:30 ET	Significant Reduction in Heart Attacks Shown in Patients Taking Pfizer's Lipitor ---- New Data Further Supports Benefits Of Intensively Treating High Cholesterol To Reduce Cardiac Events
Mar 04, 04
09:50 ET	Pfizer and Aventis Seek Approval to Market Exubera(R) in Europe
Feb 27, 04
17:15 ET	Pfizer Says Inconclusive Results From Viagra Studies in Women Do Not Support Regulatory Filing
15:50 ET	U.S. Appeals Court Upholds Patent for Pfizer's Norvasc
Feb 19, 04
18:30 ET	Pfizer to Discontinue Development of Anti-Infective Compound DK-507k
Feb 16, 04
09:10 ET	Pfizer Says Dismissal of University of Rochester COX-2 Use Patent Lawsuit Affirmed by U.S. Court of Appeals
Feb 10, 04
14:25 ET	Federal Appeals Court Upholds Dismissal of Lawsuit Involving Pfizer Medicine Zoloft
Feb 09, 04
09:14 ET	FDA to Re-Evaluate Dr. Reddy Application On Amlodipine Maleate, Pfizer Says
Feb 05, 04
08:33 ET	Pfizer Inc Announces Completion of the Tender Offer Relating to Esperion Therapeutics, Inc. Common Shares
Feb 02, 04
15:57 ET	FDA Approves Pfizer Medicine Caduet For The Treatment of Hypertension and High Cholesterol
Jan 28, 04
10:47 ET	European Regulators Grants Sildenafil Orphan Drug Designation For Pulmonary Arterial Hypertension
Jan 27, 04
09:56 ET	Pfizer Submits Supplemental New Drug Application Requesting Changes In Geodon(R) Product Label
Jan 22, 04
06:32 ET	/SECOND AND FINAL ADD -- NYTH048 -- Pfizer Inc Earnings/
06:31 ET	/FIRST ADD -- NYTH048 -- Pfizer Inc Earnings/
06:30 ET	Pfizer Inc 2003 Performance Report
Jan 20, 04
10:33 ET	Pfizer's Zithromax Receives FDA Approval as a Once-Daily, Three-Day Treatment for Acute Bacterial Sinusitis
Jan 19, 04
11:03 ET	Pfizer Agrees to Sell Its In-Vitro Allergy and Autoimmune Diagnostic Testing Business to Triton and PPM
Dec 29, 03
16:28 ET	Appeals Court Rules in Pfizer's Favor in Patent Case
Dec 21, 03
13:06 ET